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The origin of myofi broblasts remains uncertain, but studies suggest that the epi-
thelial cells may acquire a fi broblast-like phenotype via epithelial-mesenchymal tran-
sition (EMT). Objective of the study was to investigate whether EMT may contrib-
ute to the development of kidney fi brosis in a model of angiotensin II-dependent 
hypertension and to identify the role of ET-1 via ETA/ETB receptors. Transgenic rats 
TGRen2 (n=35) received for 4 weeks one of the following treatments a) irbesartan, 
b) bosentan, non selective ETA /ETB receptor antagonist, c) BMS-182874, selective 
ETA,antagonist, d) BMS+irbesartan, e) placebo.  EMT was assessed by investigat-
ing coexpression of a marker of epithelial cell (E-cadherin) and one of myofi broblast 
(S100A4 or alfa-SMA) with double immunoﬂ uorescence. Specifi c immunoreactivity 
was measured using QWinStandard Leica ImageTMsoftware. A reduction in blood 
pressure was found only with irbesartan, whereas both bosentan and irbesartan sig-
nifi cantly lowered tubulo-interstitial fi brosis. Coexpression of E-cadherin and S100A4, 
or E-cadherin and alfa-SMA, markedly decreased in the tubular cells of TGRen2 
treated with irbesartan or bosentan. Alfa-SMA expression decreased after irbesartan, 
bosentan and BMS+irbesartan, but not after BMS. S100A4 expression was reduced 
after irbesartan, bosentan and BMS+irbesartan. E-cadherin  increased only after irbe-
sartan. Coexpression of the markers of myofi broblasts and kidney epithelial cells, by 
demonstrating the development of EMT during the onset of kidney hypertension-
induced damage, suggests a crucial role of EMT in the pathogenesis of Ang II-medi-
ated fi brosis. The reduction of myofi broblast markers not only after irbesartan, but 
also after blockade of ETA/ETB receptors, suggests an involvement of ET-1 in the 
development of Ang II-mediated EMT.
